• Subscribe
  • Webinars
  • White Papers
  • Buyer's Guide
  • PhotonicsNXT
  • Get Published!
    • Recent Quotes
    My Watchlist
    Indicators
    BioOptics Stock Watch
    Markets
    Stocks
    ETFs
    Tools
    Overview
    News
    Currencies
    International
    Treasuries

    Cartesian Therapeutics, Inc. - Common Stock (NQ: RNAC )

    13.00 -1.04 (-7.41%)
    Streaming Delayed Price Updated: 2:33 PM EDT, Sep 6, 2024 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    All News about Cartesian Therapeutics, Inc. - Common Stock

    RNAC Stock Earnings: Cartesian Therapeutics Beats EPS, Beats Revenue for Q2 2024
    RNAC stock results show that Cartesian Therapeutics beat analyst estimates for earnings per share and beat on revenue for the second quarter of 2024. 
    Via InvestorPlace
    Why NIO Shares Are Trading Lower By Over 8%? Here Are Other Stocks Moving In Friday's Mid-Day Session
    Shares of NIO Inc. (NYSE:NIO) fell sharply during Friday's session after the company disclosed that Steven Wei Feng has resigned as the Chief Financial Officer for personal and family 
    Via Benzinga
    Cartesian Therapeutics Plummets On 'Watershed Moment' For CAR-T Drugs
    The company is the first to test a CAR-T drug against a placebo in patients with an autoimmune disease. 
    Via Investor's Business Daily
    Cartesian's Autoimmune Disorder Candidate Hits Primary Goal In Mid-Stage Study, Announces Equity Raise Of $130M
    Cartesian Therapeutics reported Phase 2b trial results for Descartes-08 in generalized myasthenia gravis, showing significant improvements in MG Composite scores with a favorable safety profile. The... 
    Via Benzinga
    RNAC Stock Earnings: Cartesian Therapeutics Misses EPS, Beats Revenue for Q1 2024
    RNAC stock results show that Cartesian Therapeutics missed analyst estimates for earnings per share but beat on revenue for the first quarter of 2024. 
    Via InvestorPlace
    Cartesian Therapeutics Announces New Employment Inducement Grants
    From Cartesian Therapeutics, Inc.
    Via Business Wire
    HealthStream Reports Upbeat Results, Joins Spotify, Ryder System And Other Big Stocks Moving Higher On Tuesday
    Via Benzinga
    Why Nucor Shares Are Trading Lower? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
    Via Benzinga
    Cartesian Therapeutics to Present at the ASGCT 27th Annual Meeting
    From Cartesian Therapeutics, Inc.
    Via Business Wire
    Why Skillsoft Shares Are Trading Lower By Around 27%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
    Shares of Skillsoft Corp. (NASDAQ: SKIL) fell sharply during Tuesday’s session after the company reported mixed fourth-quarter financial results and issued FY25 revenue guidance below estimates. 
    Via Benzinga
    12 Health Care Stocks Moving In Monday's Pre-Market Session
    Via Benzinga
    Cartesian Therapeutics' Rare Disease Candidate Shows Long Lasting Benefit Over Argenx's Vyvgart, Analyst Initiates With Buy
    Cartesian Therapeutics' autoimmune disease treatment with re-dosable mRNA CAR-Ts. Learn about Descartes-08, a promising anti-BCMA CAR-T therapy offering deeper, longer-lasting efficacy than current... 
    Via Benzinga
    Cartesian Therapeutics to Participate in the 23rd Annual Needham Virtual Healthcare Conference
    From Cartesian Therapeutics, Inc.
    Via Business Wire
    Cartesian Therapeutics Announces New Employment Inducement Grants
    From Cartesian Therapeutics
    Via Business Wire
    12 Health Care Stocks Moving In Thursday's After-Market Session
    Via Benzinga
    LivePerson And 2 Other Stocks Under $2 Insiders Are Buying
    The Dow Jones index closed higher by around 75 points on Monday. When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders... 
    Via Benzinga
    Topics Stocks
    Exposures US Equities
    RNAC Stock Earnings: Cartesian Therapeutics Misses EPS, Beats Revenue for Q4 2023
    RNAC stock results show that Cartesian Therapeutics missed analyst estimates for earnings per share but beat on revenue for the fourth quarter of 2023. 
    Via InvestorPlace
    SolarEdge Layoffs 2024: What to Know About the Latest SEDG Job Cuts
    SolarEdge layoffs are coming for 16% of the company's workers as it prepares to reduce its total headcount by 900 employees. 
    Via InvestorPlace
    Topics Workforce
    Exposures Layoff
    Why Is Cartesian Therapeutics (RNAC) Stock Down 5% Today?
    Cartesian Therapeutics stock is falling on Monday as investors react to a delisting notice for RNAC shares due to its low trading price. 
    Via InvestorPlace
    Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday
    We're starting the trading week with a breakdown of the biggest pre-market stock movers worth knowing about on Monday! 
    Via InvestorPlace
    12 Health Care Stocks Moving In Wednesday's After-Market Session
    Via Benzinga
    12 Health Care Stocks Moving In Friday's Intraday Session
    Via Benzinga
    Data & News supplied by www.cloudquote.io
    Stock quotes supplied by Barchart
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the following
    Privacy Policy and Terms and Conditions.